|Raymond James & Associates, Inc.||Reni Benjamin, Ph.D.|
|Oppenheimer & Co. Inc.||Leland Gershell, M.D., Ph.D.|
|Chardan||Keay Nakae, CFA|
|H. C. Wainwright & Co.||Raghuram Selvaraju, Ph.D.|
|Maxim Group LLC||Jason McCarthy|
|Dawson James Securities, Inc.||Jason Kolbert|
|Laidlaw & Company (UK) Ltd.||Yale Jen, Ph.D.|
ADMA Biologics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding ADMA Biologics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ADMA Biologics, Inc. or its management. ADMA Biologics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.